chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dehydrated; Shaking; chills; This spontaneous case was reported by a consumer and describes the occurrence of DEHYDRATION (Dehydrated), TREMOR (Shaking) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DEHYDRATION (Dehydrated), TREMOR (Shaking) and CHILLS (chills). At the time of the report, DEHYDRATION (Dehydrated), TREMOR (Shaking) and CHILLS (chills) outcome was unknown.            No concomitant medications were reported.  No treatment details were reported.
10 days after injection, 01/25/2021, left arm became itchy at injection site. When I looked at arm, it has a large pink oval spot, warm to the touch, under the injection site. Itching stopped overnight. Woke up next day 01/26/2021, with headache, very tired and nausea and gagging. This is my third day feeling sick. Not as bad but still turned from eating.
NSTEMI  - ED visit to hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
Extreme tiredness  4 days out; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration, on 17Mar2021, at 12:00, (at the age of 60 years), on left arm, as a single dose for COVID-19 immunisation. Medical history included sulfas allergy, bactrim and other urinary tract infection antibiotics however the patient was ok with cephalex. Concomitant medications included VRAYLAR, NEURONTIN, aspirin (MANUFACTURER UNKNOWN), lovastatin (MANUFACTURER UNKNOWN), LUVOX started on unknown date for unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Mar2021, at 1200 the patient experienced extreme tiredness and 4 days out. Therapeutic measure were not taken for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of tiredness was not recovered at time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Three injections in HPV4 (Human papillomavirus, quadrivalent) series provided on 01/07/2008,  08/08/2007,  05/11/2007. Began to experience gradually increasing joint pain in June 2007, with nodule formation (on right wrist) by August 2007. Joint pain, swelling, redness increased until diagnosed with rheumatoid arthritis in September 2008.  12/22/08 Reviewed PCP clinic records. FINAL DX:Rheumatoid arthritis; right wrist tenosynovitis.  Records reveal patient experienced right wrist pain since 2/07.  PRogressed to include multiple joints w/AM stiffness, difficulty sleeping due to pain.  Seen by PCP, PT & ortho.  Failed conservative treatment.  Referred to Rheum & seen 8/08 & second opinion 9/08.  Tx w/steroids & antiarthritis meds.  Responded well to steroids & continued arthritis meds w/intermittent use of steroids.
The day after shot upper arm was hot, swollen (about the size of palm was swollen) and red.
Employee broke out in hives. She plans to take BENADRYL, and if that does not alleviate symptoms, she has been advised to seek medical treatment.
Red, hard swollen, itchy and warm to touch area at vaccination site. 8 inches by 8 inches approximately.
Slight itchiness and redness a few inches below the injection site in patch about 5cms across. Treated itch with Cortizone-10. Itchiness subsided after a few days. Redness began about two days after injection and lasted about one week.
Myalgia, Fever, Rash & NauseaVomiting Narrative:
Black and blue mark on left side of neck.; Aches and pains through shoulders and back.; pains through shoulders and back.; pains through shoulders and back; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EL3248) via an unspecified route of administration on left arm on 24Mar2021 at 09:45 (at the age of 38 years old) as a single dose for COVID-19 immunisation. The medical history and concomitant medications were not reported. The patients known allergies were reported as no. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 25Mar2021, the patient started to experience black and blue marks on the left sides of his neck, aches and pains through shoulders and back. No therapeutic measures were taken for the reported adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events black and blue mark on the left sides of his neck, aches and pains through shoulders and back was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
No other AE. No PQC.; The second dose of PEDVAX HIB that was administered was expired; This spontaneous report has been received from a medical assistant referring to a 4-month-old patient of unknown gender. The patient's pertinent medical history, drug reactions, allergies, and concomitant therapies were not reported. On an unspecified date in 2021, the patient received the first dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) at the age of 2 months.   On 14-JUL-2021, the patient was vaccinated with the second dose, which was expired, of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) (dose, route of administration, anatomical site of vaccination were not provided; lot number r027320 has been verified to be a valid lot number, expiration date 08-JUL-2021) (expired product administered). The reporter stated that the vaccine did not experience a temperature excursion prior to administration. No additional adverse events (AEs) reported.
2/11/2021 - Sore swollen left arm with rash around injection site. 2/12/21 Awoke with swollen left side of neck and sore left lymph under ear/jaw bone. 2/17/21 - Shortness of breath, chest tightness, dizzy, trouble thinking. Went to  ER 3/07/2021 - To - High heart beat, blood pressure, nausea, dizzy, have trouble thinking. Blood pressure back under control but dizziness and nausea when up and thinking problems continue.
Patient received influenza vaccination 11/08/04, two days later developed a rash on limbs and buttocks that later spread to the face. Morphology ultimately consistent with Gianotti-Cresti.
Acute severe headaches and blurred vision after vaccine and acute ischemic stroke with resulting right hemianopsia
Client was inadvertently given Moderna COVID vaccine dose #1 on 2/22/2021 at Teacher vaccination POD.  Per Department of Health guidance, it was stated that it was ok, with parental permission, for client to receive dose #2 of Moderna before her 18th birthday.  Although permissible per DH, a VAERS report needs to be submitted.
Redness; Blistered arm; Rash; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), BLISTER (Blistered arm) and RASH (Rash) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ERYTHEMA (Redness) (seriousness criterion medically significant), BLISTER (Blistered arm) (seriousness criterion medically significant) and RASH (Rash) (seriousness criterion medically significant). At the time of the report, ERYTHEMA (Redness), BLISTER (Blistered arm) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.; Sender's Comments: This case concerns a 77-year-old female with medically significant and serious unexpected events of blistered arm, rash, and erythema. Event onset the same day as first dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Rash to neck and chest and face was puffy per patient. States she "took a Benadryl and symptoms faded." Right arm at injection site was red, swollen, and tender all the way to elbow. Swelling and redness worse on 06/13/14. Pt reported to health department. No rash or puffiness noted to face, neck or chest area. Right arm with redness, swelling, measured 48mm. Pt c/o tenderness. Told pt to put cool compress to area and take Motrin, if not allergies to Motrin. If swelling, redness worsens to report to doctor by 06/14/14. Call health department week of 06/16/14 to follow-up.
-  Extreme nausea  - Tenderness in gut -  Fatigue  -  Esophageal pressure -  Sick feeling when ate food -  Light-colored stool -  Abnormal bowel quantities that tapered off over the course of 20 days - Pain in arm  - Lasted for 20 days
Rash/still having rashes 2.5 months after second dose/mostly in her armpits/flat, red rash; Arm itchy/not as itchy as after her first dose; feel a slight tingling in the upper creases at the very top of her legs and also under her breasts; which will sometimes get red; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Rash/still having rashes 2.5 months after second dose/mostly in her armpits/flat, red rash), PRURITUS (Arm itchy/not as itchy as after her first dose), PARAESTHESIA (feel a slight tingling in the upper creases at the very top of her legs and also under her breasts) and ERYTHEMA (which will sometimes get red) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 004M20A) for COVID-19 vaccination.     No Medical History Reported.  Concomitant products included LOSARTAN for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (Rash/still having rashes 2.5 months after second dose/mostly in her armpits/flat, red rash), PRURITUS (Arm itchy/not as itchy as after her first dose), PARAESTHESIA (feel a slight tingling in the upper creases at the very top of her legs and also under her breasts) and ERYTHEMA (which will sometimes get red). The patient was treated with CORTISONE at an unspecified dose and frequency. At the time of the report, RASH ERYTHEMATOUS (Rash/still having rashes 2.5 months after second dose/mostly in her armpits/flat, red rash) and PRURITUS (Arm itchy/not as itchy as after her first dose) had not resolved and PARAESTHESIA (feel a slight tingling in the upper creases at the very top of her legs and also under her breasts) and ERYTHEMA (which will sometimes get red) outcome was unknown. Not Provided          With the second one she took a zyrtec an hour before receiving the vaccine. Treatment medications included Cortisone.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up added on 10-May-2021: Events added. Reporter details and contact info updated. On 26-May-2021: Follow up on 26-May-2021: Included no new information
really hurting this time; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (DOSE NUMBER UNKNOWN (BOOSTER), MANUFACTURER UNKNOWN), for Covid-19 immunization. The following information was reported: PAIN (non-serious), outcome "unknown", described as "really hurting this time".  Additional information: The patient was an older lady who was taking lot of other medications. The patient was on second booster and had event. The patient asked if she would be recommended Tylenol or Ibuprofen.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient received COVID vaccine #1 on 3/25/21 and #2 on 4/17/2021.  He had CBC done on 3/3/21 which showed normal CBC with WBC 4.4 and platelet 172K.  On 5/3/2021 with routine CBC, it showed WBC 2.3 and platelet 10K.  On 5/7/2021, WBC 0.3 and platelet 16K.  Methotrexate was D/C'd then.  He was given dexamethasone 40mg daily for 4 days for presumed ITP, completed on 5/10/2021.  On 5/12/2021, WBC 2.9 and platelet 122K.  Methotrexate still on hold.
After flu vaccine was injected, patient became very delusional with hallucinations and malaise. She believed there were people in the room when there were actually no one present. She was in her own bed and she believed she was in a hotel overseas. She became irate and demanded we take her home. This is very unusual behavior on her part. She has never been diagnosed with Alzheimers.
1. Erythema - suspected cellulitis of left arm started 9days after vaccination - started a Keflex. 2. Diffuse papular/pustular rash started 1 days after vaccination suspected generalized vaccina - also 1cm ulcer on tongue and noted with generalized rash.
ACUTE NON ST ELEVATION MI 12/12/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
24-36 hours of feeling extra tired, foggy brain, weak knees & fluttery stomach, & sore injection site with redness at the area.  Then I returned to normal.
Inflammation on injection site; Skin Sensitivity on injcetion site; Swelling on injection site; Itching at injection site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE INFLAMMATION (Inflammation on injection site), VACCINATION SITE DYSAESTHESIA (Skin Sensitivity on injcetion site), VACCINATION SITE SWELLING (Swelling on injection site) and VACCINATION SITE PRURITUS (Itching at injection site) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INFLAMMATION (Inflammation on injection site), VACCINATION SITE DYSAESTHESIA (Skin Sensitivity on injcetion site), VACCINATION SITE SWELLING (Swelling on injection site) and VACCINATION SITE PRURITUS (Itching at injection site). At the time of the report, VACCINATION SITE INFLAMMATION (Inflammation on injection site), VACCINATION SITE DYSAESTHESIA (Skin Sensitivity on injcetion site), VACCINATION SITE SWELLING (Swelling on injection site) and VACCINATION SITE PRURITUS (Itching at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment for the event included aleve.  This case is under data review.; Sender's Comments: This case is under data review
No additional AE reported; administered the second dose of VAQTA on 17NOV2021; however the dose was not due to be administered until 25NOV2021; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided.  On an unknown date, the patient was vaccinated with the first dose of Hepatitis A Vaccine, Inactivated (VAQTA) (dose, lot #, expiration date, route and site of administration were not reported) for prophylaxis.  On 17-NOV-2021, the patient was vaccinated with the second dose of Hepatitis A Vaccine, Inactivated (VAQTA) 0.5 milliliter, lot # T031202 was confirmed to be valid, expiration date 14-JUN-2022, (route and site of administration were not reported) for prophylaxis, however the second dose was not due to be administered until 25-NOV-2021 (Inappropriate schedule of vaccine administered). No additional adverse event was reported.
Pain to left upper arm area started 2 days after vaccine as still hurts today. Also had tick bite to area on day pain began. Reported 09/24/2010.
99.8 F fever, body aches, headache, chills, fatigue, trouble sleeping
The client tested positive for COVID19 shortly after her second dose in the two dose series of the Moderna vaccine.
Pt had fever/chills, vomiting, uncontrolled urination, and temporarily unable to stand/walk. Pt is still using walker day after, but is able to move about.
Fever 103.8 Perspiration  Generalized fatigue and weakness Mild dyspnea without cough- now resolved.  Soreness at injection site right arm.
Rash on the abdomen and right leg. Applying hydrocortisone cream to the rash site. Still having a rash 3 days later.
Saw MD 17SEP91 - rxn to Pertussis; inc fever 103; WBC 26,000; tx w/APAP & DPH; rash left thigh; returned 18SEP91 WBC dec; rash gone;
Pt says that arm was fine for a week when had shot administered but a week later her arm started to hurt.  Pts left arm hurts when lifting things.  She has not been to the doctor yet.
chills; light headaches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 73 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 31Mar2021 (Lot number: EP6955, Expiration Date: 30Jun2021) at the age of 73 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "open heart surgery", start date: 2016, stop date: 2016; "Allergy for penicillins" (unspecified if ongoing), notes: He got a rash when he took the penicillin. He doesn't know which penicillin caused the rash.; "Allergy for milk" (unspecified if ongoing), notes: allergic to some foods like cantaloupe and milk.; "Allergy for food" (unspecified if ongoing), notes: allergic to some foods like cantaloupe. Concomitant medication(s) included: ASPIRIN (E.C.) (ongoing).  The following information was reported: CHILLS (non-serious) with onset 01Apr2021, outcome "not recovered", described as "chills"; HEADACHE (non-serious) with onset 01Apr2021, outcome "not recovered", described as "light headaches".  Additional information: The patient reported side effect since he had the first dose of the Pfizer vaccine on 31Mar2021. And had ongoing chills and slight headaches and how long it lasted he wanted to know and asked the recommendations for 2nd dose after experiencing side effects. His symptoms were not severe but they are continuous. He reports he does not take any prescription drugs but he does take Aspirin 81mg one tablet at night. He also takes some vitamins. He saw his cardiologist last week but he did not mention his symptoms to his cardiologist. He did tell his cardiologist he had received his first Covid 19 vaccine. He has an appointment to see his primary care doctor on 10Mar2021. No history of all previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines administered on same date with the Pfizer vaccine considered as suspect. The AE(s) did not require to visit to emergency room and physician office. No Prior Vaccinations (within 4 weeks) and no AE(s) following prior vaccinations. No Relevant Tests.  No follow-up attempts are possible. No further information is expected.
Starting day 2 after the second dose (first dose March 17, second April 16 2021) my left arm feels like someone hit my arm with tremendous force. I have much less range of motion because the pain is too uncomfortable (like a charley horse). Ever since April 18 when this started I have had problems sleep as I cannot lay on my left arm; work is hard because many positions my arm hurts like I just received a debilitating blow (as in a punch) in the arm. My range of motion continues to downgrade. Given my experiences as an adult playing sports, getting sprained muscles, etc. this condition is causing severe limitations to the point I honestly felt a need to submit at least a warning if nothing else.
Left shoulder pain. MD appt. day after. Followed up with Orthopedics.
2 days following vaccine admin patient developed full body hyperpigmented oval shaped patches across lower extremities, trunk and back. Rash was all over body.  Different from identified "Covid Arm" rash noted in article.   Slightly itchy/irritating but only mildly so.   Rash has persisted now for 1 month.   Looks similar to a pityriasis rash.   Associated with some lower extremity edema as well.   No other systemic syx of allergy - no dyspnea, difficulty with swallowing, wheezing, hives, etc.
24 hours after shot noted 1 small "bug bite" like sore at site of Left thigh vaccination. 32 hour after shot-8cmx8cm raised, hard, red, warm area. Itching. Seen 3-9-07 by Medical doctor-Prednisone, Benadryl, monitor ordered. Follow up 3-13-07 redness gone, site less hard. 3/15 no redness left, 25 cent hard area yet tender skin. 3-16-07 25 cent area under skin felt knot.
heartburn; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Sep2022 at 09:00 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DYSPEPSIA (non-serious) with onset 12Sep2022 at 20:30, outcome "unknown", described as "heartburn".  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Sick to my stomach, fever, headache, muscle ache, extremely tired, foggy head, itchy eyelids, later on swollen  & red eyelids, rosacea pustules on my nose.  This happened both times as well as with Covid, only Covid was more extreme.  Now finally I feel like myself again after 3 months of heck.
Had severe headache, diarrhea, fever 102F, pain in joints and spine. No treatment given.
Increased coughing, irritability, low grade fever, excessive mucous with vomiting of mucous, some wheezing, difficulty sleeping and nursing.
4/28, 4/29 fever, nl exam. 4/30 diarrhea.
Joint pain and muscle aches.  Same as I experienced when suffering from the Covid infection. This lasted for several hours.  I took Tylenol1300 mg.  with rest.